Skip to main content

Table 4 ACORN Clinical Outcomes: Means, Standard Deviations and Group Differences Across Follow-up Periods

From: Adapting and testing a brief intervention to reduce maternal anxiety during pregnancy (ACORN): report of a feasibility randomized controlled trial

Measure Condition Baseline 10 Weeks Post Randomization t 18 Weeks Post Randomization t 34 Weeks Post Randomization t 1
GAD-7 χ2 = 89.38*** TAU 9.53 (4.52) 7.58 (4.72) −1.89* 6.64 (5.43) −1.37 5.74 (4.86) −1.26
Treatment 10.28 (4.41) 6.40 (3.75)   5.97 (4.31)   5.20 (4.17)  
EPDS χ2 = 87.26*** TAU 11.39 (5.15) 10.51 (5.23) −2.29** 9.52 (5.33) −2.25** 8.44 (5.00) −2.68***
Treatment 13.56 (4.52) 10.37 (4.34)   9.37 (4.63)   7.86 (4.91)  
PRAQ χ2 = 25.76*** TAU 25.98 (4.1) 24.66 (4.2) −.13 23.65 (4.7) −22.89*** n/a  
Treatment 25.67 (5.4) 22.99 (3.9)   23.19 (5.2)   n/a  
DAS χ2 = 6.72 TAU 120.33 (15.4) 120.91 (20.0) −.35 118.72 (16.8) .32 115.89 (22.3) .72
Treatment 118.97 (16.8) 118.35 (23.3)   118.74 (23.3)   117.06 (20.3)  
EQ5D χ2 = 1876.27*** TAU 6.60 (1.32) 6.9 (1.63) −1.23 7.03 (1.86) .30 5.84 (1.11) .38
Treatment 6.97 (1.43) 7.2 (1.21)   7.49 (1.63)   6.32 (1.45)  
  1. Note. EPDS (Edinburgh Postnatal Depression Scale; Cox, Holden, & Sagovsky, 1987), PRA (Pregnancy-Related Anxiety scale; Rini, Dunkel-Schetter, Wadhwa, & Sandman, 1999); DAS (Dyadic Adjustment Scale; Spanier, 1976), EQ5D (EuroQol-5D-3 L measure; EuroQol, 1990)
  2. ***p < 0.01
  3. **p < 0.05
  4. * p < 0.1